The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I think this current state of affairs will be the norm now until our next bit of news, which is hopefully what we are expecting and good to get this moving on again. Gone a bit boring now. Show me the money
Someone is colour blind? Shorters are.
Seems a bit over the top to me 5%/9p down on 150,000 shares traded......MM's must be really bored
So that’s now over 3 weeks since Affimers were provided to Cytiva...anyone here starting to get worried? Even the slightest hint of a delay or problem and this will be back under £1...
Also wanted to clarify what people class as mid summer launch? Mid summer is technically 15th July, which gives approximately 6 weeks to get sensitivity / specificity data stats, submit these to regulatory authorities and gain approval, then commence manufacture... given this a new type of test, scrutiny will be higher so review length will be longer IMO.
So are we really looking at a late August / September launch here at best?
And why has it taken over 3 weeks for Cytiva to produce a prototype? Not as easy as first thought?
Why would anyone be worried except nobs like you... things take time especially perfecting it. Alistair doesn’t want a half finished test which has problems and will damage the reputation. Go big or go home, I suspect they are perfecting the prototype before announcing its completion, to make it harder for people to scrutinise. Avacta “will have the best test on the market”. You don’t get the best test by rushing things. This won’t go back below £1 either, as soon as people like you sell the sooner this share will become more stable and go up and up.
Shearclass why do you try keep trying deramp this ?
NCYT holder with sub par sales and a french rejection and french listing..... filtered
Shearclass Your joking FDA are throwing out certificates like petrol bombs
I’d also like to point out Shearglass that your posting history has been negative about AVCT for a long time. Post written 20th may -
Avacta have stated that they were working on a test from mid March but didn’t inform the market until 8th April.
Kamani and Hughes bought £2m of shares on 2nd April stating it was to support current strategy. They then set a company up 3 weeks later to sell tests.
Were they aware of the test when they subscribed?
Was this why IP group were so happy to sell their 15% shareholding at 18p?
Was this why Alan Aubrey resigned?
Answers on a postcard, but this stinks if you ask me.
Answers on a post card but you stink if you ask me, constantly trying to ramp down a share - get a life. Sad little individual.
As well as that, you also posted on the 16th may -
Bad news for AVCT, great news for the world... IMO shows big pharma are right to focus on Antibodies rather than untried Affimers
How are these negative posts working out for you so far? Stop trying, go get some fresh air it’s a nice day, instead of sitting in a basement all day trying to instill worry into new investors - most who have done our research take no notice of your ridiculous posts.
The slightest hint of delay will not drop this under £1. What would drop this under £1 is AVCT posting an RNS to say the test is ready to keep you happy that they have got your interpretation of a few weeks, then it get thrown out by the FDA or other bodies for being sub optimal! This is the pharma business and people’s lives that are impacted. You have to get it right, and getting it right takes time.
A few more days for me is okay - AS could kill the future reputation of Affimers and this business (which weren’t initially designed for COVID), in one fell swoop with a sub optimal test. Now that would kill the share price.
This is the pharma business - think about it!
Good post jdt1990. Avacta is more than just Covid testing. Sure the future Affimer value has not been proven yet but the last thing we want is to damage that future potential. A few months ago this was never in the plan for the product development so the team will want to do it quickly but do it right.
We are still on plan so people need to stop assuming there is a delay. I just reread the Adeptrix RNS from 1st May and it said the test would be ready to start trials, approvals, manufacture in June. I fully expect news on this front first and in the next ‘few’ weeks too. As Ophidian nicely put it, this could be the new ‘gold standard’ test!
Look at the news out of India today on new infections. Covid-19 isn’t going anywhere this year unfortunately so we need progress on all fronts.
Yes, & comparing this company to a wildcat driller seems slightly odd in my opinion. They’ve been working on their platform for years..You only need to look at the partnerships over the last couple of years to get a feeling of how this company’s regarded.
Sh*tCrass, do you feel insecure about your holdings in ncyt? And see avct a threat? Simply invest in avct in addition to being ncyt. After all you invest to make money not to fall in love a stock, which unfortunately most do. I was a long term holder in ncyt and felt there were other better opportunities such as avct, normal investment behaviour which most do. I repeat what I said to your ‘colleague’ in idiocy from ncyt: give 2 weeks and we’ll see which direction the sp of avct and nyct will take. That was about 2/3 weeks ago....and it happened exactly as said: avct up by more than 40/50% while ncyt down by 20/30%. So will it happen in the next 2 weeks. Not wishing ncyt to go down or their investors lose money- I never do-, but that is the reality that your type refuse to see because you either don’t do proper research or idiocy runs your brain. Good luck to you with ncyt and good luck to us with avct- FAIR??? In AVCT case everything is in place: distribution, manufacturing of the test and possible clinical trials as we speak....all that is needed is THE announcement via THE RNS.
Before anyone says 'its not about today'.....I know all that but crikey considering we have up until this morning already endured quite a retreat in a relatively short space of time from the 2.15 high .........we are taking a right pounding today!!